These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17667921)

  • 1. NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas.
    Górka B; Skubis-Zegadło J; Mikula M; Bardadin K; Paliczka E; Czarnocka B
    Br J Cancer; 2007 Aug; 97(4):531-8. PubMed ID: 17667921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive Feedback Loops Between NrCAM and Major Signaling Pathways Contribute to Thyroid Tumorigenesis.
    Zhang Y; Sui F; Ma J; Ren X; Guan H; Yang Q; Shi J; Ji M; Shi B; Sun Y; Hou P
    J Clin Endocrinol Metab; 2017 Feb; 102(2):613-624. PubMed ID: 27732334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High periostin expression correlates with aggressiveness in papillary thyroid carcinomas.
    Puppin C; Fabbro D; Dima M; Di Loreto C; Puxeddu E; Filetti S; Russo D; Damante G
    J Endocrinol; 2008 May; 197(2):401-8. PubMed ID: 18434370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
    Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours.
    Marques AR; Espadinha C; Frias MJ; Roque L; Catarino AL; Sobrinho LG; Leite V
    Br J Cancer; 2004 Aug; 91(4):732-8. PubMed ID: 15238980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid.
    Bièche I; Ruffet E; Zweibaum A; Vildé F; Lidereau R; Franc B
    Thyroid; 1997 Oct; 7(5):725-31. PubMed ID: 9349575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated expression of VHL mRNA variants in papillary thyroid cancer.
    Baldini E; Tuccilli C; Arlot-Bonnemains Y; Chesnel F; Sorrenti S; De Vito C; Catania A; D'Armiento E; Antonelli A; Fallahi P; Watutantrige-Fernando S; Tartaglia F; Barollo S; Mian C; Bononi M; Arceri S; Mascagni D; Vergine M; Pironi D; Monti M; Filippini A; Ulisse S
    Mol Cell Endocrinol; 2017 Mar; 443():121-127. PubMed ID: 28089820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas.
    Degl'Innocenti D; Alberti C; Castellano G; Greco A; Miranda C; Pierotti MA; Seregni E; Borrello MG; Canevari S; Tomassetti A
    PLoS One; 2010 Sep; 5(9):e12701. PubMed ID: 20877637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma.
    Yang X; Hu Y; Shi H; Zhang C; Wang Z; Liu X; Chen H; Zhang L; Cui D
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2127-2134. PubMed ID: 29951933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene expression of metalloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer].
    Hucz J; Kowalska M; Jarzab M; Wiench M
    Endokrynol Pol; 2006; 57 Suppl A():18-25. PubMed ID: 17091452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.
    Fisher KE; Jani JC; Fisher SB; Foulks C; Hill CE; Weber CJ; Cohen C; Sharma J
    J Surg Res; 2013 Nov; 185(1):217-24. PubMed ID: 23746767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism.
    Durante C; Puxeddu E; Ferretti E; Morisi R; Moretti S; Bruno R; Barbi F; Avenia N; Scipioni A; Verrienti A; Tosi E; Cavaliere A; Gulino A; Filetti S; Russo D
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2840-3. PubMed ID: 17488796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas.
    Bruland O; Fluge Ø; Akslen LA; Eiken HG; Lillehaug JR; Varhaug JE; Knappskog PM
    BMC Cancer; 2009 Dec; 9():425. PubMed ID: 19968886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of laminin 332 in lymph node metastasis of papillary thyroid carcinoma.
    Oh KH; Choi J; Woo JS; Baek SK; Jung KY; Koh MJ; Kim YS; Kwon SY
    Auris Nasus Larynx; 2017 Dec; 44(6):729-734. PubMed ID: 28238469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.